Mary’s Medicinals, a leading medicinal cannabis company based in Colorado, just landed a significant cannabinoid patent.
The awarded patent pertains to Mary’s Medicinals Transdermal Cannbinoid Gel Pen and the company’s product’s formulations, thus securing protection for the company’s intellectual property. To the best of this author’s knowledge, this patent registration represents the first of its kind to a non-pharmaceutical/government related company for a cannabinoid-related formula (England-based GW Pharmaceuticals also has one).
Mary’s Medicinals initially applied for the patent in December of 2014, so the lengthy process took a year and a half to come full circle. Now, the company created the world’s first known transdermal cannabinoid formula has secured its future.
And it’s a big deal as you can see from the company’s press release:
Mary’s Medicinals, developer of award-winning cannabis products including the first transdermal cannabis patch, announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) on May 10, 2016 for its innovative transdermal cannabinoid gel technology.
“We are pleased that the Patent and Trademark Office has approved our application,” said Nicole Smith, founder & CEO, Mary’s Medicinals. “The PTO has only granted an extremely limited number of cannabis-related patents – almost exclusively to major international pharmaceutical corporations, research institutions and the Federal Government. As a small startup company, securing this protection for our intellectual property and the recognition of the uniqueness of our offerings will bolster our continued leadership in this rapidly growing industry.”
The company also stated that it has more patent applications pending for some of its other proprietary products. Here’s what the gel pen looks like:
Mary’s Medicinals has deservedly gained a reputation as one of the more consistent, legitimate cannabis businesses in Colorado. With its wide array of delivery methods and many CBD-centric (cannabidiol) products and now this patent, Mary’s Medicinals appears very poised to continue gaining momentum as an industry titan.